Director Dan Lemaitre sells entire 14,375-share position at GMED for $1.2M; holds zero post-transaction.
Director Dan Lemaitre completed a complete exit of his GMED holdings through 2 separate sales on 2024-11-21 and 2024-11-22, selling 13,278 shares at $85.00 and 1,097 shares at $85.02 for a combined $1,221,893.21. The blended average price of $85.00 is just 0.5% below the 52-week high of $84.91, positioning this sale near peak valuation. His cross-ticker track record shows a 90-day well-timed rate of 0.00%, indicating his prior sells have not preceded declines; notably, his single prior sale at GMED on 2024-05-10 generated a positive 90-day return of +14.4%, suggesting the stock moved up after that earlier exit. The complete liquidation of a director's holdings warrants close observation of both the timing signal and any broader context around liquidity needs or confidence shifts, particularly given the company's elevated P/E of 126.10 and recent 90-day appreciation of +17.8%.